AstraZeneca PLC is 171.8x more valuable than Biohaven Ltd. by market capitalization ($286.27 B vs $1.67 B). Every figure below comes from audited SEC filings and refreshed market data.
| Metric | BHVN | AZN |
|---|---|---|
| Market cap | $1.67 B | $286.27 B |
| US-listed rank | #2237 | #45 |
| Net income (latest FY) | -$738.82M | - |
| SEC filings | 265 | 1,004 |
AstraZeneca PLC is 171.8x more valuable than Biohaven Ltd. by market capitalization ($286.27 B vs $1.67 B).
Full pages: Biohaven Ltd. and AstraZeneca PLC, or browse the full rankings.